Log In
Print
BCIQ
Print
Print this Print this
 

Tuberculosis vaccine (MVA85A, MVA85A/AERAS-485)

Also known as: AERAS-485

  Manage Alerts
Collapse Summary General Information
Company Emergent BioSolutions Inc.
DescriptionRecombinant modified Vaccinia Ankara (rMVA) virus expressing Mycobacterium tuberculosis antigen 85A
Molecular Target
Mechanism of ActionVaccine
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationTuberculosis
Indication DetailsPrevent tuberculosis (TB) infection; Prevent tuberculosis (TB) infection in HIV-positive patients
Regulatory Designation

Partner

Aeras Global TB Vaccine Foundation


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today